scholarly journals Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience

Drug Safety ◽  
2018 ◽  
Vol 41 (12) ◽  
pp. 1431-1437 ◽  
Author(s):  
John F. Marcinak ◽  
Melvin S. Munsaka ◽  
Paul B. Watkins ◽  
Takashi Ohira ◽  
Neila Smith
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Liver Safety ◽  
Trial Experience ◽  
Global Clinical Trial ◽  
Clinical Trial Experience

Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience

Drug Safety ◽  
2018 ◽  
Vol 41 (6) ◽  
pp. 625-640 ◽  
Author(s):  
John F. Marcinak ◽  
Melvin S. Munsaka ◽  
Paul B. Watkins ◽  
Takashi Ohira ◽  
Neila Smith
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Liver Safety ◽  
Trial Experience ◽  
Global Clinical Trial ◽  
Clinical Trial Experience

scholarly journals Healthcare and associated costs related to type 2 diabetes in youth and adolescence: the TODAY clinical trial experience

2019 ◽  
Author(s):  
Thomas J. Songer ◽  
Morey W. Haymond ◽  
Judith E. Glazner ◽  
Georgeanna J. Klingensmith ◽  
Lori M. Laffel ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Trial Experience ◽  
Clinical Trial Experience ◽  
Diabetes In Youth

scholarly journals Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience

2016 ◽  
Vol 12 (4) ◽  
pp. 337-345 ◽  
Author(s):  
M. D. Marcus ◽  
D. E. Wilfley ◽  
L. El ghormli ◽  
P. Zeitler ◽  
B. Linder ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Weight Change ◽  
Onset Type ◽  
Trial Experience ◽  
Clinical Trial Experience

Diabetes Remission Clinical Trial (DiRECT)—Plasma Liver Function Tests Reflect Change in Liver Fat Content in Early Type 2 Diabetes

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1834-P
Author(s):  
SVIATLANA V. ZHYZHNEUSKAYA ◽  
AHMAD AL-MRABEH ◽  
CARL PETERS ◽  
ALISON C. BARNES ◽  
KIEREN G. HOLLINGSWORTH ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Liver Function ◽  
Liver Function Tests ◽  
Fat Content ◽  
Diabetes Remission ◽  
Liver Fat ◽  
Early Type ◽  
Liver Fat Content

66-OR: Remission of Type 2 Diabetes for Two Years Is Associated with Full Recovery of Beta-Cell Functional Mass in the Diabetes Remission Clinical Trial (DiRECT)

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 66-OR
Author(s):  
SVIATLANA V. ZHYZHNEUSKAYA ◽  
AHMAD AL-MRABEH ◽  
ALISON C. BARNES ◽  
BENJAMIN ARIBISALA ◽  
KIEREN G. HOLLINGSWORTH ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Beta Cell ◽  
Diabetes Remission ◽  
Full Recovery
Sign in / Sign up

Export Citation Format

Share Document